Contract Pharma Magazine
September 2022
-
Biomanufacturing Technology Trends
Avoiding product oxidation by H2O2 in isolators. It all depends on the right analyses!09.07.22
-
Leadership Spotlight: Thomas Otto & Peter Soelkner
Vetter's managing directors share business insights and talk CDMO industry trends.09.07.22
-
Responding to Consumer Complaints While Working with CMOs
Whether their products are pharmaceuticals, medical devices or combination products, manufacturers face questions about how to respond to consumer complaints.09.07.22
-
Future Pandemic Preparedness
The lessons COVID-19 has taught us and the way forward to protect global public health.09.07.22
-
Cell and Gene Therapy Contract Manufacturers Are Critical to Industry Success
CDMOs hold the key to lack of industry capacity, hiring challenges.09.07.22
-
Why Robotic Sterile Fill-Finish Is Key for Speed to Clinic and Patient Safety
Sterile fill-finish is a mainstay in pharmaceutical manufacturing and robotic platforms will be a true differentiator.09.07.22
-
Aseptic Manufacturing: Key Trends, Challenges and the Importance of the Right CDMO Partner
Key considerations for successful aseptic manufacturing and lyophilization.09.07.22
-
Managing Your CareerDealing with a Bad BossYou’re in the hot seat in this difficult relationship.09.13.22
-
FDA WatchConsiderations When Outsourcing Stability TestingStability studies are a critical element of drug development and a key commitment in maintaining product on the market.09.13.22
-
Back PageKeeping Quality Levels High in your CMO RelationshipsBuilding a comprehensive quality and compliance strategy when partnering with CMOs is vital for success.09.07.22
-
-
ColumnsIndia Moves to Uphold Patient Safety in Clinical TrialsTougher laws on the anvil to curb breach.09.07.22
-
Columns“Insurmountable Opportunities” May Really Be Silver LiningsRapid NIR instruments are making it possible to monitor tablets in real time.09.07.22
